A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Following the onset of nonarteritic anterior ischemic optic neuropathy, regular stroke workup may be necessary.

MONDAY, Feb. 10, 2025 (HealthDay News) -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.